Advertisement

Supply Chain



The U.S. Food and Drug Administration has announced its approval for an implantable device that decreases the number of seizures for patients with drug-resistant epilepsy.

The market for pre-owned medical devices is expected to grow by a compound annual growth rate of 10.6 percent from 2013 until 2019, bringing the market value to $4.9 billion, according to a news release.

The Food and Drug Administration has issued a document outlining a voluntary process that can be used to expedite device development and evaluation of medical device development tools in the Center for Devices and Radiological Health.

The rate of spending on global prescription drugs is approaching its lowest point in decades, according to a report by the Intercontinental Marketing Services Institute for Healthcare Informatics.

The Food and Drug Administration has issued a Class I recall of about 15,000 guidewires on various Medtronic heart devices, saying the defective coating on the wires could cause serious injury or death.

Advertisement

Most Read

Advertisement
Advertisement